BioPharma

Discover how AI is transforming personalised medicine and patient-specific treatments and how data integration can revolutionise drug discovery and healthcare.

Discover how AI and protein pattern analysis are transforming disease prediction. Latest research from Optima Partners, Biogen, and the University of Edinburgh.

Discover how Otsuka and Oxford HIN are collaborating to evaluate and implement CARE for MDD, a digital therapeutic designed to treat major depressive disorder.

Discover how AI and patient-on-chip technology are revolutionising drug discovery and development.

Explore the challenges and strategic solutions involved in integrating AI into established legacy systems in the Pharma Industry.

Discover how AI is transforming drug discovery and the future of AI in pharmaceutical research.

Discover how Artificial Intelligence (AI) is revolutionizing pharmaceutical research and development in this insightful article featuring Renee Iacona, Vice President of Oncology Biometrics at AstraZe...

Bringing a new drug to market typically takes a decade or more and approximately US$2.5 billion. However, new technology, including AI, can dramatically shorten the drug discovery process and reduce t...

We speak to Elanco, Bayer, Janssen and Ipsen to find out what they think will be the biggest changes in the industry over the next year

In this interview, Phillip Hewitt, Head of Early Investigative Toxicology at Merck KGaA analyzes new innovations in predictive toxicology

L.E.K. Consulting share the five key success factors needed for a biopharma launch

This paper explores how a single, enterprise data-management platform can improve biologics development lifecycles. The paper examines the challenges faced by biopharmaceutical professionals in thei...